Konsume
Interval Day Week Month
Newswire Search Past 90 Days 24 stories 17 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
rasonque3-
Prominent Journalists
Byline Articles Written Avg Reach
Gayathry Prakash 3 -
RTTNews Staff Writer 2 -
Frank Vinluan 2 -
Chris Markoch 1 -
by PR Newswire 1 -
By Reuters 1 -
REUTERS 1 -
Berkeley Lovelace Jr. 1 -
Nathaniel Weixel 1 -
Khloe Quill 1 -
FRANCE 24 1 -
Ed Silverman 1 -
Bloomberg News 1 -
Hilary Brueck 1 -
Ed Cara 1 -
By Salong Debbarma 1 -
Meghana Keshavan, Andrew Joseph 1 -
Meghana Keshavan, Jonathan Wosen 1 -


Medicilon Presents Revolution Medicines with the "Excellence in Client Partnership Award" – Thailand Business News

by PR Newswire — thailand-business-news.com


Tango builds on Revolution Medicines' pancreatic cancer success

Meghana Keshavan, Jonathan Wosen — statnews.com


RevMed's pancreatic cancer drug nears European approval

Meghana Keshavan, Andrew Joseph — statnews.com


Revolution Medicines' Pancreatic Cancer Drug Gets Positive EU Review

RTTNews Staff Writer — rttnews.com


Propanc Reports Positive Preclinical Pancreatic Cancer Data For PRP; Phase 1b Planned In Q1 2027

Gayathry Prakash — rttnews.com


This Pill Will Change Cancer Treatment Forever

Ed Cara — gizmodo.com


Merck Pays $400M for Cancer Drug Prospect From China-Based SciBrunch

Frank Vinluan — medcitynews.com


Revolution Medicines' Daraxonrasib Secures FDA Breakthrough Designation In Pancreatic Cancer

Gayathry Prakash — rttnews.com


Two scientists made huge bets on 'impossible' cancer treatments. They're finally paying off.

Hilary Brueck — businessinsider.com


Revolution Medicines Got Its Breakthrough—What Moves It Next?

Chris Markoch — marketbeat.com

Execution: 2.42 Seconds. 31.85 mb used.